Bioblast Announces Results of Trehalose Clinical Study
Go back to Bioblast Announces Results of Trehalose Clinical Study| Orient Paper, Inc. NEW (NASDAQ: ORPN) | Delayed: 11.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.50 | 52 Week High | $7.95 | |||
| Open | $10.61 | 52 Week Low | $1.36 | |||
| Day High | $11.50 | P/E | 21.30 | |||
| Day Low | $11.50 | EPS | $0.54 | |||
| Volume | 903,889 | |||||
